SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-007811
Filing Date
2019-03-14
Accepted
2019-03-14 21:19:53
Documents
2
Period of Report
2019-03-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1556
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4105
  Complete submission text file 0000899243-19-007811.txt   7182
Mailing Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139 857-529-8300
X4 Pharmaceuticals, Inc (Issuer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O FIVE CORNERS CAPITAL 700 WEST GEORGIA STREET, SUITE 2500 VANCOUVER A1 V7Y 1B3
Business Address
Bridger Gary (Reporting) CIK: 0001600049 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38295 | Film No.: 19682693